Homocystinuria-Megaloblastic Anemia due to Defect in Cobalamin Metabolism, CblE Complementation Type
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
Homocystinuria-Megaloblastic Anemia due to Defect in Cobalamin Metabolism, CblE Complementation Type
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
Clinical onset and course, response to treatment and outcome in 24 patients with the cblE or cblG remethylation defect complemented by genetic and in vitro enzyme study data.
|
25526710 |
2015 |
Homocystinuria-Megaloblastic Anemia due to Defect in Cobalamin Metabolism, CblE Complementation Type
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
cblE type of homocystinuria due to methionine synthase reductase deficiency: functional correction by minigene expression.
|
15714522 |
2005 |
Homocystinuria-Megaloblastic Anemia due to Defect in Cobalamin Metabolism, CblE Complementation Type
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Molecular basis for methionine synthase reductase deficiency in patients belonging to the cblE complementation group of disorders in folatecobalamin metabolism.
|
10484769 |
1999 |
Homocystinuria-Megaloblastic Anemia due to Defect in Cobalamin Metabolism, CblE Complementation Type
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria.
|
9501215 |
1998 |
Homocystinuria-Megaloblastic Anemia due to Defect in Cobalamin Metabolism, CblE Complementation Type
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria.
|
9501215 |
1998 |
Homocystinuria-Megaloblastic Anemia due to Defect in Cobalamin Metabolism, CblE Complementation Type
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria.
|
9501215 |
1998 |
Homocystinuria-Megaloblastic Anemia due to Defect in Cobalamin Metabolism, CblE Complementation Type
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Homocystinuria-Megaloblastic Anemia due to Defect in Cobalamin Metabolism, CblE Complementation Type
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Homocystinuria-Megaloblastic Anemia due to Defect in Cobalamin Metabolism, CblE Complementation Type
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
Neural tube defect, folate-sensitive
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
Neural tube defect, folate-sensitive
|
0.500 |
Biomarker
|
disease |
CTD_human |
|
|
|
Homocystinuria
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
The prevalent c.903+469T>C mutation in MTRR causes the cblE type of homocystinuria by strengthening an SRSF1 binding site in an ESE leading to activation of a pseudoexon.
|
25878036 |
2015 |
Homocystinuria
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
Methionine synthase reductase (MTRR) is the locus of the cblE class of inborn errors of cobalamin metabolism that is characterized by megaloblastic anemia and homocystinuria.
|
17554763 |
2007 |
Homocystinuria
|
0.460 |
Biomarker
|
disease |
CTD_human |
cblE type of homocystinuria due to methionine synthase reductase deficiency: functional correction by minigene expression.
|
15714522 |
2005 |
Homocystinuria
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
cblE type of homocystinuria due to methionine synthase reductase deficiency: functional correction by minigene expression.
|
15714522 |
2005 |
Homocystinuria
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
CblE type of homocystinuria: mild clinical phenotype in two patients homozygous for a novel mutation in the MTRR gene.
|
12971424 |
2003 |
Homocystinuria
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
Our study expands the knowledge of the phenotypic and genotypic variability of the cblE type of homocystinuria and supports the concept that this disorder is caused by mutations in the MTRR gene.
|
12555939 |
2002 |
Homocystinuria
|
0.460 |
Biomarker
|
disease |
CTD_human |
CblE type of homocystinuria due to methionine synthase reductase deficiency: clinical and molecular studies and prenatal diagnosis in two families.
|
12555939 |
2002 |
Homocystinuria
|
0.460 |
Biomarker
|
disease |
BEFREE |
Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria.
|
9501215 |
1998 |
Homocystinuria
|
0.460 |
Biomarker
|
disease |
HPO |
|
|
|
Colorectal Carcinoma
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
This case-control study enrolled 105 new cases of CRC, 101 of colorectal adenoma (CRA), and 182 controls from hospitals in Bangkok, Thailand, to examine the association between folate status and methylenetetrahydrofolate reductase (MTHFR) 677C > T, methionine synthase (MTR) 2756A > G, and methionine synthase reductase (MTRR) 66A > G with the risk of CRC and CRA.
|
31740010 |
2019 |
Colorectal Carcinoma
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
MTRR rs1801394 and its interaction with MTHFR rs1801133 in colorectal cancer: a case-control study and meta-analysis.
|
28691890 |
2017 |
Colorectal Carcinoma
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
Our pooled data suggest an association between MTRR A66G polymorphism and CRC susceptibility among Caucasians.
|
26214647 |
2015 |
Colorectal Carcinoma
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
The MTR and MTRR polymorphisms were unrelated to colorectal cancer risk.
|
24377513 |
2013 |